Use of Mobile Phone Application for Asthma Sele Management

March 26, 2025 updated by: Kamuzu University of Health Sciences

Feasibility and Acceptability of Asthma Self-Management Delivered Through a Mobile Phone Application: a Pilot Study in Malawi

This study aimed to assess the feasibility and acceptability of self-management provided through a mobile application.

Study Overview

Status

Completed

Conditions

Detailed Description

The chronic nature of asthma management requires a long-term approach taking into account the variability of disease symptoms, triggers and exacerbations. Several current guidelines advocate for self-management as part of standard care. Low-income countries (LMICs) such as Malawi are experiencing an increase in the burden of disease which hinders delivery of self-management services. Mobile phone health applications (mHealth) has been reported as an effective and cost-effective tool in the monitoring and management of asthma.

Study Type

Observational

Enrollment (Actual)

17

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Malawi
      • Blantyre, Malawi
        • Kamuzu University of Malawi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

All asthma patients aged 10 years and over attending pediatric outpatient clinic.

Description

Inclusion Criteria:

  1. Be aged 10 years and over
  2. Have a Physician diagnosis of asthma and be prescribed a salbutamol inhaler
  3. Reside in Blantyre
  4. Participants should be able to read and write either English or Chichewa with Minimum standard 5 eductaion

Exclusion Criteria:

  1. Cognitively impaired
  2. Presence of coormobities
  3. Refues to consent
  4. Presence of active lung disease other than athsma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
GINA Symptom Control Assessment
Time Frame: one year
Asthma Control Test (ATC) Score
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kamuzu University of Health Sciences

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention,2019. Available from www.ginasthma.org

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 11, 2020

Primary Completion (Actual)

December 30, 2021

Study Completion (Actual)

December 30, 2021

Study Registration Dates

First Submitted

March 26, 2025

First Submitted That Met QC Criteria

March 26, 2025

First Posted (Actual)

March 28, 2025

Study Record Updates

Last Update Posted (Actual)

March 28, 2025

Last Update Submitted That Met QC Criteria

March 26, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.09/20/3132
  • 5U24HL136791 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The de-identified datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

IPD Sharing Time Frame

1 year

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asthma Self Management

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe